Literature DB >> 21930606

Failure of topical antibiotics to prevent disseminated Borrelia burgdorferi infection following a tick bite in C3H/HeJ mice.

Gary P Wormser1, Thomas J Daniels, Susan Bittker, Denise Cooper, Guiqing Wang, Charles S Pavia.   

Abstract

A prior study in mice has shown that the timely application of topical antibiotics to the skin at the tick bite site could eradicate Borrelia burgdorferi infection. That study, however, did not evaluate antibiotic preparations that are considered suitable for use in humans. In this murine study, topical application of 2% erythromycin and 3% tetracycline preparations that are acceptable for use in humans was found to be ineffective in eliminating B. burgdorferi from the tick bite site or in preventing dissemination to other tissues. Reasons for the discrepant findings are discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21930606      PMCID: PMC3415953          DOI: 10.1093/infdis/jir382

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Impact of genotypic variation of Borrelia burgdorferi sensu stricto on kinetics of dissemination and severity of disease in C3H/HeJ mice.

Authors:  G Wang; C Ojaimi; R Iyer; V Saksenberg; S A McClain; G P Wormser; I Schwartz
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

2.  The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

Authors:  Gary P Wormser; Raymond J Dattwyler; Eugene D Shapiro; John J Halperin; Allen C Steere; Mark S Klempner; Peter J Krause; Johan S Bakken; Franc Strle; Gerold Stanek; Linda Bockenstedt; Durland Fish; J Stephen Dumler; Robert B Nadelman
Journal:  Clin Infect Dis       Date:  2006-10-02       Impact factor: 9.079

3.  Absence of acquired resistance to nymphal Ixodes ricinus ticks in BALB/c mice developing cutaneous reactions.

Authors:  M L Mbow; M Christe; B Rutti; M Brossard
Journal:  J Parasitol       Date:  1994-02       Impact factor: 1.276

4.  Activity of sera from patients with Lyme disease against Borrelia burgdorferi.

Authors:  C S Pavia; G P Wormser; G L Norman
Journal:  Clin Infect Dis       Date:  1997-07       Impact factor: 9.079

5.  Erythromycin resistance in Borrelia burgdorferi.

Authors:  Darya Terekhova; Marina L Sartakova; Gary P Wormser; Ira Schwartz; Felipe C Cabello
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

6.  Delayed dissemination of Lyme disease spirochetes from the site of deposition in the skin of mice.

Authors:  C M Shih; R J Pollack; S R Telford; A Spielman
Journal:  J Infect Dis       Date:  1992-10       Impact factor: 5.226

7.  Topical prophylaxis for Lyme disease after tick bite in a rodent model.

Authors:  C M Shih; A Spielman
Journal:  J Infect Dis       Date:  1993-10       Impact factor: 5.226

8.  Rapid dissemination by the agent of Lyme disease in hosts that permit fulminating infection.

Authors:  C M Shih; S R Telford; R J Pollack; A Spielman
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

9.  Antiborrelial activity of serum from rats injected with the Lyme disease spirochete.

Authors:  C S Pavia; V Kissel; S Bittker; F Cabello; S Levine
Journal:  J Infect Dis       Date:  1991-03       Impact factor: 5.226

10.  Impaired host defense to infection and Toll-like receptor 2-independent killing of Borrelia burgdorferi clinical isolates in TLR2-deficient C3H/HeJ mice.

Authors:  Guiqing Wang; Ying Ma; Arzu Buyuk; Steve McClain; Janis J Weis; Ira Schwartz
Journal:  FEMS Microbiol Lett       Date:  2004-02-16       Impact factor: 2.742

  10 in total
  2 in total

1.  Efficacy of an experimental azithromycin cream for prophylaxis of tick-transmitted lyme disease spirochete infection in a murine model.

Authors:  Joseph Piesman; Andrias Hojgaard; Amy J Ullmann; Marc C Dolan
Journal:  Antimicrob Agents Chemother       Date:  2013-10-28       Impact factor: 5.191

2.  Identification of new drug candidates against Borrelia burgdorferi using high-throughput screening.

Authors:  Venkata Raveendra Pothineni; Dhananjay Wagh; Mustafeez Mujtaba Babar; Mohammed Inayathullah; David Solow-Cordero; Kwang-Min Kim; Aneesh V Samineni; Mansi B Parekh; Lobat Tayebi; Jayakumar Rajadas
Journal:  Drug Des Devel Ther       Date:  2016-04-01       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.